...
首页> 外文期刊>The American Journal of the Medical Sciences >Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization
【24h】

Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization

机译:患者急性肾损伤在住院期间继续对肾素 - 血管紧张素系统阻滞剂

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background Acute kidney injury (AKI) is common in hospitalized patients and is associated with adverse outcomes. This study aimed to evaluate patient characteristics and interventions during hospitalization associated with the development of AKI in patients continued on renin-angiotensin system (RAS) blockers during hospitalization. Methods A retrospective study of 184 adult patients admitted between January 2012 and September 2014 and continued on RAS blockers was conducted. Risk factors for AKI were compared between AKI ( n = 92) and non-AKI ( n = 92) groups. Results Patients who developed hospital-acquired AKI had a higher baseline serum creatinine (1.2 ± 0.4 versus 1 ± 0.3 mg/dL, P 0.001) and lower estimated glomerular filtration rate (54 ± 10 versus 57 ± 7 mL/minute/1.73 m 2 , P = 0.03) compared with patients who did not develop AKI. Patients who developed AKI were also more likely to be admitted to the intensive care unit, have surgical procedures, have hypotension and be prescribed loop diuretics. The presence of chronic kidney disease and hypotension were risk factors associated with AKI development. In addition, the AKI group had a significantly longer length of stay (14 days versus 8 days, P 0.0001) and had a higher rate of all-cause hospital mortality (9% versus 1%, P = 0.03). Conclusions Patients with chronic kidney disease, hypotension and those undergoing surgeries were more likely to develop AKI while receiving RAS blockers. During hospitalization, temporary discontinuation of these medications may be warranted in patients with these characteristics.
机译:摘要背景急性肾脏损伤(AKI)在住院患者中是常见的,与不利结果有关。本研究旨在评估与在住院期间患者持续的患者的患者发育的住院期间的患者特征和干预措施。方法对2012年1月至2014年1月和9月持续的184名成人患者进行了回顾性研究,并继续对RAS阻拦者进行。在AKI(n = 92)和非AKI(n = 92)组之间比较AKI的危险因素。结果开发出医院获得的AKI的患者具有更高的基线血清肌酐(1.2±0.4与1±0.3mg / dL,P <0.001),较低的估计肾小球过滤速率(54±10对57±7毫升/分钟/ 1.73与没有开发AKI的患者相比,M 2,P = 0.03)。开发AKI的患者也更有可能被录取到重症监护病房,具有外科手术,具有低血压并被规定的环路利尿剂。慢性肾病和低血压的存在是与AKI开发相关的风险因素。此外,AKI集团的住宿时间明显更长(14天与8天,P& 0.0001),并具有较高的全因医院死亡率(9%与1%,P = 0.03)。结论慢性肾病,低血压和接受手术的患者更有可能在接受RAS阻滞剂时开发AKI。住院期间,可能在这些特征的患者中临时停药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号